References
- Rubio-Agusti I, Salavert M, Bataller L. Limbic encephalitis and related cortical syndromes. Curr Treat Options Neurol. 2013; 15:169–84.
- Iorio R, Lennon VA. Neural antigen-specific autoimmune disorders. Immunol Rev. 2012; 248:104–21.
- McKeon A, Pittock SJ. Paraneoplastic encephalomyelopathies: pathology and mechanisms. Acta Neuropathol. 2011; 122:381–400.
- Dalmau J, Graus F. Antibody-mediated encephalitis. N Engl J Med. 2018; 378:840–51.
- Shin YW, Lee ST, Park KI, Jung KH, Jung KY, Lee SK, et al. Treatment strategies for autoimmune encephalitis. Ther Adv Neurol Disord. 2017; 11:1756285617722347. doi: 10.1177/1756285617722347
- Nosadini M, Mohammad SS, Ramanathan S, Brilot F, Dale RC. Immune therapy in autoimmune encephalitis: a systematic review. Expert Rev Neurother. 2015; 15:1391–419.
- Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016; 12:1–13.
- Jacob S, Rajabally YA. Current proposed mechanisms of action of intravenous immunoglobulins in inflammatory neuropathies. Curr Neuropharmacol. 2009; 7:337–42.
- Centers for Disease Control and Prevention (CDC). Outbreak of hepatitis C associated with intravenous immunoglobulin administration – United States, October 1993–June 1994. MMWR Morb Mortal Wkly Rep. 1994; 43:505–9.
- Ring J, Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet. 1977; 1:466–9.
- Brettle RP, Gross M, Legg NJ, Lockwood M, Pallis C. Treatment of acute polyneuropathy by plasma exchange. Lancet. 1978; 2:1100. doi: 10.1016/S0140-6736(78)91837-8
- Guo Y, Tian X, Wang X, Xiao Z. Adverse effects of immunoglobulin therapy. Front Immunol. 2018; 9:1299. doi: 10.3389/fimmu.2018.01299
- Orlin JB, Berkman EM. Partial plasma exchange using albumin replacement: removal and recovery of normal plasma constituents. Blood. 1980; 56:1055–9.
- Chirnside A, Urbaniak SJ, Prowse CV, Keller AJ. Coagulation abnormalities following intensive plasma exchange on the cell separator. II. Effects on factors I, II, V, VII, VIII, IX, X and antithrombin III. Br J Haematol. 1981; 48:627–34.
- Stigelman WH Jr, Henry DH, Talbert RL, Townsend RJ. Removal of prednisone and prednisolone by plasma exchange. Clin Pharm. 1984; 3:402–7.
- Pohl MA, Lan SP, Berl T. Plasmapheresis does not increase the risk for infection in immunosuppressed patients with severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. Ann Intern Med. 1991; 114:924–9.
- Mokrzycki MH, Kaplan AA. Therapeutic plasma exchange: complications and management. Am J Kidney Dis. 1994; 23:817–27.
- Lu J, Zhang L, Xia C, Tao Y. Complications of therapeutic plasma exchange: a retrospective study of 1201 procedures in 435 children. Medicine (Baltimore). 2019; 98:e18308. doi: 10.1097/MD.0000000000018308
- Klinov V, Campellone J. Comparison of length of hospital stay between treatment with plasma exchange versus IVIG in mild Guillain-Barré Syndrome. (P7.064). Neurology. 2015; 84(14 Suppl):P7.064. doi: 10.1212/WNL.84.14_supplement.P7.064
- Graus F, Titulaer MJ, Balu R, Benseler S, Bien CG, Cellucci T, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016; 15:391–404.
- Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013; 41:580–637.
- Daenen K, Huijben JA, Boyd A, Bos LDJ, Stoof SCM, van Willigen H, et al. Optimal dosing and timing of high-dose corticosteroid therapy in hospitalized patients with COVID-19: study protocol for a retrospective observational multicenter study (SELECT). JMIR Res Protoc. 2023; 12:e48183. doi: 10.2196/48183
- Sae-lao S. A prospective RCT of 2% chlorhexidine in 70% ethanol, compared with 5% povidone-iodine in 70% ethanol as cutaneous antiseptics for prevention of central venous catheter colonization [Master’s thesis, Chulalongkorn University]. Chulalongkorn University Intellectual Repository; 2014.
- Jeon CY, Neidell M, Jia H, Sinisi M, Larson E. On the role of length of stay in healthcare-associated bloodstream infection. Infect Control Hosp Epidemiol. 2012; 33:1213–8.
- Tess BH, Glenister HM, Rodrigues LC, Wagner MB. Incidence of hospital-acquired infection and length of hospital stay. Eur J Clin Microbiol Infect Dis. 1993; 12:81–6.
- Dulworth S, Pyenson B. Healthcare-associated infections and length of hospital stay in the Medicare population. Am J Med Qual. 2004; 19:121–7.